======= ZFYVE20 ======= == Gene Information == * **Official Symbol**: RBSN * **Official Name**: rabenosyn, RAB effector * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64145|64145]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H1K0|Q9H1K0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZFYVE20&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZFYVE20|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609511|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that belongs to the FYVE zinc finger family of proteins. The encoded protein interacts with Ras-related proteins that regulate membrane trafficking. A missense mutation in this gene is associated with a defect in the early endocytic pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]. * **UniProt Summary**: Rab4/Rab5 effector protein acting in early endocytic membrane fusion and membrane trafficking of recycling endosomes. Required for endosome fusion either homotypically or with clathrin coated vesicles. Plays a role in the lysosomal trafficking of CTSD/cathepsin D from the Golgi to lysosomes. Also promotes the recycling of transferrin directly from early endosomes to the plasma membrane. Binds phospholipid vesicles containing phosphatidylinositol 3-phosphate (PtdInsP3) (PubMed:11062261, PubMed:11788822, PubMed:15020713). Plays a role in the recycling of transferrin receptor to the plasma membrane (PubMed:22308388). {ECO:0000269|PubMed:11062261, ECO:0000269|PubMed:11788822, ECO:0000269|PubMed:15020713, ECO:0000269|PubMed:22308388}. |FYVE| |Rbsn| |Golgi to lysosome transport| |early endosome to Golgi transport| |Golgi to vacuole transport| |regulation of Golgi organization| |retrograde transport, endosome to Golgi| |post-Golgi vesicle-mediated transport| |lysosomal transport| |vacuolar transport| |cytosolic transport| |Rab GTPase binding| |early endosome membrane| |nucleic acid binding| |endosome membrane| |endosomal transport| |endosome| |blood coagulation| |coagulation| |hemostasis| |Golgi vesicle transport| |wound healing| |regulation of body fluid levels| |response to wounding| |intracellular membrane-bounded organelle| |zinc ion binding| |regulation of organelle organization| |protein transport| |intracellular transport| |peptide transport| |amide transport| |establishment of protein localization| |establishment of localization in cell| |nitrogen compound transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp459|Bleomycin 5μM R08 exp459]]|-2.79| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-2.6| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-2.4| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|-2.12| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|-2.04| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.03| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.93| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.89| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|-1.87| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.87| |[[:results:exp477|DKK1 89ng/ml R08 exp477]]|-1.79| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|-1.78| |[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|-1.73| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|-1.73| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.71| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.73| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.76| |[[:results:exp220|BAY-598 4μM R05 exp220]]|1.77| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|1.82| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|1.94| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|2.1| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|1/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2614 * **Expression level (log2 read counts)**: 5.24 {{:chemogenomics:nalm6 dist.png?nolink |}}